FDA Expands Use of DigniCap to Prevent Chemotherapy-induced Hair Loss

FDA Expands Use of DigniCap to Prevent Chemotherapy-induced Hair Loss
The DigniCap Cooling System, a scalp-cooling system designed by Dignitana to reduce hair loss due to chemotherapy, was cleared by the U.S. Food and Drug Administration (FDA) to be used in patients with solid tumor cancers, including ovarian cancer. “We are pleased to expand the use of this product for cancer patients with solid tumors

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *